Codie, I have to admit that had I followed all your advices, then I would have been a whole lot better off today.
Musclepharm got a credibility problem imo.
There is no closure of SEC investigation, there is no uplisting to Nasdaq. Three independent board members demanded by SEC just resigned. After the announcement of proxy statement, the company changed it's bylaws to protect board members, which according to Wynnefield Capital is completely unacceptable.
The Ceo defaulted on pledged stocks without any explanation whatsoever.
There was a waiver for some breach of loan terms that expired May 31, that we haven't heard anything about.
The current situation might change for the better, but for now.....I will just listen to what Codie got to say.